Office-Based Buprenorphine Treatment Program May Benefit Patients With Opioid Use Disorder Discharged From Short-Term Detox Program, Study Indicates

Psychiatry Advisor (9/19, Rans) reports, a study suggests “linkage to an office‐based buprenorphine treatment program following discharge from a short-term managed detoxification program was associated with reduced rates of illicit opioid use in patients with opioid use disorder.” The findings from the randomized trial published in Addiction showed “that patients in the short-term detoxification program had significantly reduced rates of illicit opioid use at follow-up on day 12,” 35, 95, and 185.

Related Links:

— “Post-Detoxification Primary Care Treatment Linked to Reduced Illicit Opioid Use, “Caleb Rans, Psychiatry Advisor, September 19, 2019

Posted in In The News.